Review: Metabolit Sekunder dan Aktivitas Farmakologi Tanaman Mangrove Sonneratia alba
on
Authors:
Priskila Putri Mairing, Ni Putu Ariantari
Abstract:
“Sonneratia alba is a mangrove species widely distributed in Indonesia and locally known as pidada putih or perepat. Various parts of this plant have been used in folk medicine for the treatment of bruises, sprains, malaria, appendicitis, liver, increased appetite, and stamina. This review summarizes the latest information regarding secondary metabolites and pharmacological activities of extracts and phytochemicals of the mangrove S. alba, potentially used for pharmaceutical and nutritional applications. In the last 10 years (2011-2021), a growing number of reports revealed pharmacological potential of S. alba as antibacterial and antioxidant. At least 17 secondary metabolites have been described from S. alba collected from various plant parts such as fruits, leaves, stems, and roots. In addition, various chemical classes of metabolites such as terpenoids/triterpenoids, alkaloids, flavonoids and phenolics, saponins, and steroids were reported from this plant. Keywords: Pharmacological activity, secondary metabolites, Sonneratia alba”
Keywords
Pharmacological activity, secondary metabolites, Sonneratia alba
Downloads:
Download data is not yet available.
References
References Not Available
PDF:
https://jurnal.harianregional.com/jfu/full-83635
Published
2022-07-30
How To Cite
MAIRING, Priskila Putri; ARIANTARI, Ni Putu. Review: Metabolit Sekunder dan Aktivitas Farmakologi Tanaman Mangrove Sonneratia alba.Jurnal Farmasi Udayana, [S.l.], p. 1-7, july 2022. ISSN 2622-4607. Available at: https://jurnal.harianregional.com/jfu/id-83635. Date accessed: 08 Jul. 2024. doi:https://doi.org/10.24843/JFU.2022.v11.i01.p01.
Citation Format
ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian
Issue
Vol. 11, No. 1, Tahun 2022
Section
Articles
Copyright
This work is licensed under a Creative Commons Attribution 4.0 International License
Discussion and feedback